Search

Your search keyword '"Gornet, Jean-Marc"' showing total 472 results

Search Constraints

Start Over You searched for: Author "Gornet, Jean-Marc" Remove constraint Author: "Gornet, Jean-Marc"
472 results on '"Gornet, Jean-Marc"'

Search Results

1. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases

2. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study

3. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

5. Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study

8. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

9. Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

11. Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID

12. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

13. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study

14. Recommandations françaises pour la prise en charge de la maladie de Crohn – Version courte.

15. Place de la combothérapie classique dans les MICI en 2024.

16. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

17. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

18. Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials

19. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

20. Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption

22. Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

23. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes

24. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

25. Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative

28. High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

29. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

30. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

33. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

36. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

37. Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn’s Disease

39. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

40. Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

41. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

43. Associations between the severity of medical and surgical complications and perception of surgeon empathy in esophageal and gastric cancer patients

44. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

Catalog

Books, media, physical & digital resources